［1］Chen W，Sun K，Zheng R，et al.Cancer incidence and mortality in China，2014［J］.Chin J Cancer Res，2018，30(1)：1-12.
［2］Chapman RM.Diagnosis，management，and treatment of hepatocellular carcinoma(V2011)［J］.J Clin Hepatol，2011，251(21)：2871-2872.
［3］Yamamoto M，Takasaki K，Otsubo T，et al.Favorable surgical outcomes in patients with early hepatocellular carcinoma［J］.Ann Surg，2004，239(3)：395-399.
［4］Raza SA，Jang HJ，Kim TK.Differentiating malignant from benign thrombosis in hepatocellular carcinoma：Contrast-enhanced ultrasound［J］.Abdominal Imaging，2014，39(1)：153-161.
［5］YANG YH，ZHAO XW.Comparative analysis of US and MSCT in diagnosis of hepatocellular carcinoma and focal nodular hyperplasia of the liver［J］.Chinese Journal of Operative Procedures of General Surgery(Electronic Edition)，2017，11(1)：70-72.［杨耀华，赵现伟.超声与CT检查在肝癌及肝脏局灶性结节增生中的对比分析［J］.中华普外科手术学杂志（电子版），2017，11(1)：70-72.］
［6］LI L，WU JT，LIU L.Study on the diagnostic value with multi-mode imaging of recurrent hepatocellular carcinoma［J］.Journal of Practical Medical Imaging，2017，18(1)：12-16.［李立，吴晶涛，刘丽.多模式影像对复发性肝癌的诊断价值研究［J］.实用医学影像杂志，2017，18(1)：12-16.］
［7］Nishigori S，Numata K，Irie K，et al.Fusion imaging with contrast-enhanced ultrasonography for evaluating the early therapeutic efficacy of radiofrequency ablation for small hypervascular hepatocellular carcinomas with iso-echoic or unclear margins on conventional ultrasonography［J］.Journal of Medical Ultrasonics，2018，45(3)：405-415.
［8］GUO JH，WANG LR，YANG CT，et al.Diagnostic value of contrast-enhanced ultrasound and virtual touch tissue quantification for hepatic malignant lesions［J］.Journal of Guangxi Medical University，2017，34(10)：1472-1475.［郭津含，王乐荣，杨春桃，等.超声造影联合声触诊组织量化技术对肝脏微小恶性病变的诊断价值［J］.广西医科大学学报，2017，34(10)：1472-1475.］
［9］WANG JW，CHENG XL，GAO JB，et al.64-slice spiral CT stage-4 enhanced in the diagnosis of SHCC［J］.Journal of Practical Medical Imaging，2018，19(1)：46-49.［王军委，成新玲，高剑波，等.64排螺旋CT四期增强扫描在小肝癌诊断中的应用［J］.实用医学影像杂志，2018，19(1)：46-49.］
［10］Feng Y，Jun L，Han O.Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging and multidetector-row computed tomography for the diagnosis of hepatocellular carcinoma：A systematic review and meta-analysis［J］.Medicine，2015，94(32)：e1157.
［11］Granata V，Catalano O，Fusco R，et al.The target sign in colorectal liver metastases：An atypical Gd-EOB-DTPA "uptake" on the hepatobiliary phase of MR imaging［J］.Abdominal Radiology，2015，40(7)：2364-2371.
［12］YANG JZ，WANG CJ，HUO YJ，et al.Application experience of detection and diagnosis of micro(﹤ 1.0 cm)hepatocellular carcinoma by 3.0T MRI［J］.Journal of Practical Radiology，2014，30(8)：1415-1418.［杨景震，王成健，霍英杰，等.3.0T MR检出和诊断<1.0cm 微小肝癌应用体会［J］.实用放射学杂志，2014，30(8)：1415-1418.］
［13］YIN TT，GU H，YANG RN，et al.Application of contrast-enhanced MR imaging with DWI and DCE in diagnose of recurre)nt micro-tumor foci in patients with hepatocellular carcinoma after hepatectomy［J］.Journal of Practical Hepatology，20(5)：625-626.［殷婷婷，顾红，杨儒牛，等.MRI联合应用DWI和DCE扫描序列在发现肝癌切除术后肝内复发微小癌灶的价值分析［J］.实用肝脏病杂志，2017，20(5)：625-626.］
［14］Attwa MH，El-Etreby SA.Guide for diagnosis and treatment of hepatocellular carcinoma［J］.World J Hepatol，2015，7(12)：1632-1651.
［15］Gomaa AI，Waked I.Recent advances in multidisciplinary management of hepatocellular carcinoma［J］.World J Hepatol，2015，7(4)：673-687.
［16］ZHOU YL，SHAO BF，SHI DH，et al.Correlation between PET-CT imaging and pathological grading of hepatocellular carcinoma［J］.Journal of Nantong University(Medical Sciences)，2012，32(5)：391-393.［周益龙，邵冰峰，施冬辉,等.肝细胞肝癌PET-CT显像与肿瘤病理分级的相关性研究［J］.南通大学学报（医学版），2012，32(5)：391-393.］
［17］Thandassery RB，Goenka U，Goenka MK.Role of local ablative therapy for hepatocellular carcinoma［J］.Journal of Clinical and Experimental Hepatology，2014(4)：S104-S111.
［18］Ierardi AM，Giorlando F，Piacentino F，et al.Factors predicting outcomes of microwave ablation of small hepatocellular carcinoma［J］.La Radiologia Medica，2016，122(2)：1-7.
［19］Tan CH，Low SCA，Thng CH.APASL and AASLD consensus guidelines on imaging diagnosis of hepatocellular carcinoma：A review［J］.Int J Hepatol，2011：1-11.
［20］Kang TW，Rhim H.Recent advances in tumor ablation for hepatocellular carcinoma［J］.Liver Cancer，2015，4(3)：176-187.
［21］Chen MS，Li JQ，Zheng Y，et al.A Prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma［J］.Ann Surge，2006，243(3)：321-328.
［22］Yi HM，Zhang W，Ai X，et al.Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma conforming to the Milan criteria：Systemic review and meta-analysis［J］.International Journal of Clinical and Experimental Medicine，2014，7(10)：3150-3163.
［23］Casaccia M，Santori G，Bottino G，et al.Laparoscopic resection vs laparoscopic radiofrequency ablation for the treatment of small hepatocellular carcinomas：A single-center analysis［J］.World Journal of Gastroenterology，2017，23(4)：653-660.
［24］He ZX，Xiang P，Gong JP，et al.Radiofrequency ablation versus resection for Barcelona clinic liver cancer very early/early stage hepatocellular carcinoma：A systematic review［J］.Therapeutics and Clinical Risk Management，2016(12)：295-303.
［25］Seo J，Koizumi N，Funamoto T，et al.Visual servoing for a US-guided therapeutic HIFU system by coagulated lesion tracking：A phantom study［J］.International Journal of Medical Robotics & Computer Assisted Surgery，2011，7(2)：237-247.
［26］Inoue Y，Suzuki Y，Ota M，et al.Short-and long-term results of laparoscopic parenchyma-sparing hepatectomy for small-sized hepatocellular carcinoma：A comparative study using propensity score matching analysis［J］.The American Surgeon，2018，84(2)：230-237.
［27］Luo L，Zou H，Yao Y，et al.Laparoscopic versus open hepatectomy forhepatocellular carcinoma：Short-and long-term outcomes comparison［J］.International Journal of Clinical and Experimental Medicine，2015，8(10)：18772-18778.
［28］National Health and Family Planning Comission of the People's Republic of China.Diagnosis，management，and treatment of hepatocellular carcinoma (V2017)［J］.Chinese Journal of Digestive Surgery，2017，16(7)：635-647.［中华人民共和国卫生和计划生育委员会医政医管局.原发性肝癌诊疗规范(2017年版)［J］.中华消化外科杂志，2017，16(7)：635-647.］
［29］Eltawil Karim M，Kidd Mark，Giovinazzo Francesco,et al.Differentiating the impact of anatomic and non-anatomic liver resection on early recurrence in patients with Hepatocellular Carcinoma［J］.World J Surg Oncol，2010(8)：43.
［30］LIU Y，DAI Y，ZHANG XX，et al.Comparative analysis of anatomic and non-anatomic hepatectomy for single small hepatocellular carcinoma with microvascular invasion［J］.National Medical Journal of China，2018，98(24)：1937-1940.［刘煜，代扬，张欣雪，等.单发小肝癌合并微血管侵犯解剖性与非解剖性肝切除疗效对比分析［J］.中华医学杂志，2018，98(24)：1937-1940.］
［31］Dong S，Wang Z，Wu L，et al.Effect of surgical margin in R0 hepatectomy on recurrence-free survival of patients with solitary hepatocellular carcinomas without macroscopic vascular invasion［J］.Medicine，2016，95(44)：e5251.
［32］Zhong FP，Zhang YJ，Liu Y，et al.Prognostic impact of surgical margin in patients with hepatocellular carcinoma：A meta-analysis［J］.Medicine，2017，96(37)：e8043.
［33］Kim WR，Lake JR，Smith JM，et al.OPTN/SRTR 2016 annual data report：Liver［J］.American Journal of Transplantation，2018(18)：172-253.
［34］JIAO XL，CHEN Y，LI X.Clinical effect of resection，radiofrequency ablation and transplantation for small hepatocellular carcinoma：Comparative study［J］.Practical Journal of Medicine & Pharmacy，2018，35(3)：193-196.［矫学黎，陈燚，李霞.肝切除、射频消融和肝移植三种方案治疗小肝癌的临床疗效比较［J］.实用医药杂志，2018，35(3)：193-196.］
［35］Mazzaferro V，Regalia E，Doci R，et al.Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis［J］.New England Journal of Medicine，1996，334(11)：693-700.
［36］Zheng SS，Xu X，Wu J，et al.Liver transplantation for hepatocellular carcinoma：Hangzhou experiences［J］.Transplantation，2008，85(12)：1726-1732.
［37］Fan J，Yang GS，Fu ZR，et al.Liver transplantation outcomes in 1，078 hepatocellular carcinoma patients：A multi-center experience in Shanghai，China［J］.Journal of Cancer Research & Clinical Oncology，2009，135(10)：1403-1412.
［38］Yao FY，Ferrell L，Bass NM，et al.Liver transplantation for hepatocellular carcinoma：Expansion of the tumor size limits does not adversely impact survival［J］.Hepatology，2001，33(6)：1394-1403.
［39］Sugawara Y，Tamura S，Makuuchi M.Living donor liver transplantation for hepatocellular carcinoma：tokyo university series［J］.Digestive Diseases，2007，25(4)：310-312.
［40］Amado Víctor，Rodríguez-Perálvarez Manuel，Ferrín Gustavo，et al.Selecting patients with hepatocellular carcinoma for liver transplantation：Incorporating tumor biology criteria［J］.J Hepatocell Carcinoma，2019(6)：1-10.
［41］SUN BC，LI GQ，HUANG XL，et al.Clinical application of LDLT after reconstruction of IVC using artificial blood vessel in the treatment of HCC beyond milan criteria［J］.Chin J Oncol，2018，40(3)：211-215.［孙倍成，李国强，黄新立，等.人造血管重建下腔静脉活体肝移植治疗超米兰标准肝癌的临床应用价值［J］.中华肿瘤杂志，2018，40(3)：211-215.］
［42］Mourad MM，Liossis C，Gunson BK，et al.Etiology and management of hepatic artery thrombosis after adult liver transplantation［J］.Liver Transplantation，2014，20(6)：713-723.
［43］Singh AK，Nachiappan AC，Verma HA，et al.Postoperative imaging in liver transplantation：What radiologists should know［J］.Radiographics，2010，30(2)：339.
［44］Park MS，Lee KW，Suh SW，et al.Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation［J］.Transplantation Journal，2014，97(1)：71-77.
［45］Peng ZW，Zhang YJ，Liang HH，et al.Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone：A prospective randomized trial［J］.Radiology，2012，262(2)：689-700.
［46］Schoenberg M，Khandoga A，Stintzing S，et al.CyberKnife radiosurgery-value as an adjunct to surgical treatment of HCC［J］.Cureus，2016(8)：e591.
［47］Rahbari NN，Mehrabi A，Mollberg NM，et al.Hepatocellular carcinoma：Current management and perspectives for the future［J］.Ann Surg，2011；253(3)：453-469.
［48］FAN J.The new mechanism of recurrent liver cancer metastasis and the intervention strategy［C］.Data compilation of the 15th National Academic Conference on Hepatocellular Carcinoma.Zhengzhou：Committee of the 15th National Academic Conference on Hepatocellular Carcinoma，2015：18.［樊嘉.肝癌转移复发的新机制及干预策略［C］.第十五届全国肝癌学术会议资料汇编.郑州：第十五届全国肝癌学术会议委员会，2015：18.］
［49］Gao J，Song P.Combination of triple biomarkers AFP，AFP-L3，PIVAKⅡfor early detection of hepatocellular carcinoma in China：Expectation［J］.Drug Discover 2017，11(3)：168-169.
［50］HAN S，ZHANG HK，LIU H，et al.The value of multi-arterial CAIPIRINHA-Dixon-TWIST volume-interpolated breath-hold examination in detecting new lesions in hepatocellular carcinoma patients［J］.Journal of Clinical Radiology，2018，37(09)：1493-1497.［韩帅，张宏凯，刘慧，等.MA-CDT-VIBE序列在复发肝癌的应用价值初探［J］.临床放射学杂志，2018，37(09)：1493-1497.］
［51］Liu CT，Chen YL，Li RX，et al.Analysis of contrast-enhanced ultrasound and enhanced MR and DWI findings of recurrent small hepatocellular carcinoma［J］.China Medical Devices，2019，34(03)：78-81.［刘春堂，陈勇良，李若旭,等.复发性微小肝癌超声造影与磁共振增强扫描及DWI表现分析［J］.中国医疗设备，2019，34(03)：78-81.］
［52］Frühling P，Nilsson A，Duraj F，et al.Single-center nonrandomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans：Short to mid-term results［J］.Eur J Surg Oncol，2017(43)：751-757.
［53］Li C，Li R，Zhang W.Progress in non-invasive detection of liver fibrosis［J］.Cancer Biol Med，2018，15(2)：124-136.
［54］Yan PG，Zhang L，Pan ZY.Influence of preoperative transcatheter arterial chemoembolization on prognosis after repeat curative hepatectomy for recurrent hepatocellular carcinoma［J］.Journal of Hepatopancreatobiliary Surgery，2013，25(3)：182-184.［颜品高，章琏，潘泽亚.再切除术前TACE 对复发性肝癌预后的影响［J］.肝胆胰外科杂志，2013，25(3)：182-184.］